Michael G. Muto

45.8k total citations · 2 hit papers
123 papers, 7.0k citations indexed

About

Michael G. Muto is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael G. Muto has authored 123 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Reproductive Medicine, 46 papers in Obstetrics and Gynecology and 26 papers in Pathology and Forensic Medicine. Recurrent topics in Michael G. Muto's work include Ovarian cancer diagnosis and treatment (65 papers), Endometrial and Cervical Cancer Treatments (35 papers) and Uterine Myomas and Treatments (26 papers). Michael G. Muto is often cited by papers focused on Ovarian cancer diagnosis and treatment (65 papers), Endometrial and Cervical Cancer Treatments (35 papers) and Uterine Myomas and Treatments (26 papers). Michael G. Muto collaborates with scholars based in United States, Hong Kong and Australia. Michael G. Muto's co-authors include Ross S. Berkowitz, Christopher P. Crum, Colleen M. Feltmate, Yonghee Lee, Michael J. Callahan, David W. Kindelberger, Judy E. Garber, Fabíola Medeiros, Samuel C. Mok and Alexander Miron and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Michael G. Muto

117 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship

2007 772 citations Michelle S. Hirsch, Colleen M. Feltmate et al. profile →
The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome

2006 612 citations Michael G. Muto, Colleen M. Feltmate et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael G. Muto United States	40	4.7k	2.4k	1.5k	1.4k	1.2k	123	7.0k
Russell Vang United States	52	4.1k 0.9×	2.1k 0.9×	1.5k 1.0×	637 0.5×	1.9k 1.5×	169	7.9k
Colin J.R. Stewart Australia	39	2.7k 0.6×	1.8k 0.7×	1.7k 1.1×	720 0.5×	1.9k 1.6×	208	6.7k
Jeffrey D. Seidman United States	42	3.9k 0.8×	2.2k 0.9×	862 0.6×	319 0.2×	725 0.6×	105	5.5k
Rochelle L. Garcia United States	34	2.1k 0.5×	849 0.4×	1.9k 1.2×	1.6k 1.1×	2.0k 1.6×	83	5.5k
Brooke E. Howitt United States	45	2.0k 0.4×	1.9k 0.8×	1.6k 1.1×	387 0.3×	2.1k 1.7×	156	6.7k
Matthew A. Powell United States	40	2.4k 0.5×	3.3k 1.4×	1.3k 0.8×	283 0.2×	1.1k 0.9×	182	5.7k
Franco Odicino Italy	33	3.5k 0.8×	4.0k 1.7×	1.0k 0.7×	316 0.2×	1.3k 1.1×	128	6.7k
David W. Kindelberger United States	23	2.3k 0.5×	1.1k 0.5×	777 0.5×	607 0.4×	768 0.6×	38	3.6k
Naveena Singh United Kingdom	37	2.1k 0.5×	1.8k 0.8×	703 0.5×	335 0.2×	1.5k 1.2×	144	5.2k
Carmen Tornos United States	38	2.0k 0.4×	1.9k 0.8×	950 0.6×	292 0.2×	916 0.8×	91	4.4k

Countries citing papers authored by Michael G. Muto

Since Specialization

Citations

This map shows the geographic impact of Michael G. Muto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Muto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Muto more than expected).

Fields of papers citing papers by Michael G. Muto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Muto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Muto. The network helps show where Michael G. Muto may publish in the future.

Co-authorship network of co-authors of Michael G. Muto

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Muto. A scholar is included among the top collaborators of Michael G. Muto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Muto. Michael G. Muto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lynce, Filipa, Colleen M. Feltmate, Michelle Davis, et al.. (2023). Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps. JCO Precision Oncology. 7(7). e2300290–e2300290. 6 indexed citations

Muto, Michael G., et al.. (2021). Mid-trimester cesarean scar pregnancy: a case report. SHILAP Revista de lepidopterología. 7(1). 10–10.

Yamamoto, Cindy M., Melanie Oakes, Taku Murakami, et al.. (2018). Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers. Journal of Ovarian Research. 11(1). 20–20. 55 indexed citations

Watkins, Jaclyn C., Eric Yang, Michael G. Muto, et al.. (2016). Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome. International Journal of Gynecological Pathology. 36(2). 115–127. 67 indexed citations

Huang, Kuan‐Chun, Junzheng Yang, Shu‐Kay Ng, et al.. (2016). Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells. European Journal of Cancer. 67. 152–163. 34 indexed citations

Mitra, Devarati, et al.. (2015). The risk of lymphedema after postoperative radiation therapy in endometrial cancer. Journal of Gynecologic Oncology. 27(1). e4–e4. 38 indexed citations

Viswanathan, Akila N., Hang Lee, Ross S. Berkowitz, et al.. (2013). A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer. Gynecologic Oncology. 132(1). 55–60. 17 indexed citations

Oduyebo, Titilope, Emily E. Meserve, Michael A. Seidman, et al.. (2013). The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Gynecologic Oncology. 132(2). 360–365. 100 indexed citations

Worley, Michael J., Stephanie Guseh, J. Alejandro Rauh‐Hain, et al.. (2013). Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery?. Gynecologic Oncology. 129(1). 69–73. 25 indexed citations

10.

Folkins, Ann K., Nicole Nevadunsky, Aasia Saleemuddin, et al.. (2010). Evaluation of vascular space involvement in endometrial adenocarcinomas: laparoscopic vs abdominal hysterectomies. Modern Pathology. 23(8). 1073–1079. 32 indexed citations

11.

Saleemuddin, Aasia, Ann K. Folkins, Leslie A. Garrett, et al.. (2008). Risk factors for a serous cancer precursor (“p53 signature”) in women with inherited BRCA mutations. Gynecologic Oncology. 111(2). 226–232. 58 indexed citations

12.

Huang, Lihan, Audrey P. Garrett, Michael G. Muto, et al.. (2000). Identification of a novel 9 cM deletion unit on chromosome 6q23–24 in papillary serous carcinoma of the peritoneum. Human Pathology. 31(3). 367–373. 17 indexed citations

13.

Muto, Michael G., Samuel C. Mok, Christina A. Bandera, et al.. (1995). Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum.. PubMed. 55(3). 490–2. 82 indexed citations

14.

Tsao, Sai‐Wah, Samuel C. Mok, Edward G. Fey, et al.. (1995). Characterization of Human Ovarian Surface Epithelial Cells Immortalized by Human Papilloma Viral Oncogenes (HPV-E6E7 ORFs). Experimental Cell Research. 218(2). 499–507. 182 indexed citations

15.

Muto, Michael G. & Amin I. Kassis. (1995). Monoclonal antibodies used in the detection and treatment of epithelial ovarian cancer. Cancer. 76(S10). 2016–2027. 7 indexed citations

16.

Muto, Michael G., Daniel W. Cramer, Douglas L. Brown, et al.. (1993). Screening for Ovarian Cancer: The Preliminary Experience of a Familial Ovarian Cancer Center. Gynecologic Oncology. 51(1). 12–20. 53 indexed citations

17.

Tepler, I, S A Cannistra, Emil Frei, et al.. (1993). Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.. Journal of Clinical Oncology. 11(8). 1583–1591. 67 indexed citations

18.

Muto, Michael G., Neil J. Finkler, Amin I. Kassis, et al.. (1992). Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125. Gynecologic Oncology. 45(3). 265–272. 35 indexed citations

19.

Rice, Laurel W., Janice M. Lage, Ross S. Berkowitz, et al.. (1992). Preoperative serum CA-125 levels in borderline tumors of the ovary. Gynecologic Oncology. 46(2). 226–229. 33 indexed citations

20.

Goodman, Howard M., Bernard L. Harlow, Ellen E. Sheets, et al.. (1992). The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma. Gynecologic Oncology. 46(3). 367–371. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact